TELA Bio, Inc. (TELA)
NASDAQ: TELA · IEX Real-Time Price · USD
4.630
+0.080 (1.76%)
At close: Jul 19, 2024, 4:00 PM
4.690
+0.060 (1.30%)
Pre-market: Jul 22, 2024, 7:26 AM EDT
TELA Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for TELA Bio stock have an average target of 13, with a low estimate of 10 and a high estimate of 15. The average target predicts an increase of 180.78% from the current stock price of 4.63.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for TELA Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +115.98% | May 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +223.97% | Mar 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +159.18% | Mar 22, 2024 |
| Lake Street | Lake Street | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +202.38% | Dec 27, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $20 → $15 | Buy | Maintains | $20 → $15 | +223.97% | Nov 10, 2023 |
Financial Forecast
Revenue This Year
76.91M
from 58.45M
Increased by 31.58%
Revenue Next Year
97.57M
from 76.91M
Increased by 26.86%
EPS This Year
-1.55
from -2.04
EPS Next Year
-1.24
from -1.55
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 79.7M | 104.7M | 138.4M | 168.1M | 214.0M |
| Avg | 76.9M | 97.6M | 125.6M | 163.3M | 207.9M |
| Low | 73.0M | 90.9M | 110.3M | 156.9M | 199.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.3% | 36.1% | 41.8% | 33.8% | 31.1% |
| Avg | 31.6% | 26.9% | 28.8% | 29.9% | 27.3% |
| Low | 24.9% | 18.2% | 13.0% | 24.8% | 22.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.45 | -1.02 | -0.41 | 0.51 | 1.71 |
| Avg | -1.55 | -1.24 | -0.64 | 0.50 | 1.66 |
| Low | -1.58 | -1.39 | -0.87 | 0.48 | 1.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 242.4% |
| Avg | - | - | - | - | 232.7% |
| Low | - | - | - | - | 219.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.